Emergent BioSolutions
GAITHERSBURG, MD · CIK 0001367644 · Biotech · Public
Anthrax and mpox vaccines, and opioid overdose reversal therapeutics
emergentbiosolutions.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $48M
- 1 Form D · Oct 2018
- 95 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $47,870,412 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2497 | b3 bio, inc. | — | $5.7M |
| 2498 | DUET BIOSYSTEMS, INC | — | — |
| 2499 | Trex Bio | — | — |
| 2500 | Emergent BioSolutions | — | $48M |
| 2501 | ARTELO BIOSCIENCES, INC. | — | $33M |
| 2502 | Celmatix Inc. | — | $20M |
| 2503 | Exciva | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Daniel Abdun-NabiDirector · Executive Officer
- Sue BaileyDirector
- Fuad El-HibriDirector · Executive Officer
- Zsolt HarsanyiDirector
- Jerome HauerDirector
- Adam HaveyExecutive Officer
- George JoulwanDirector
- Robert KramerExecutive Officer
- Richard LindahlExecutive Officer
- Ronald RichardDirector
- Atul SaranExecutive Officer
- Katherine StreiExecutive Officer
- Louis SullivanDirector
- Kathryn ZoonDirector
Patents
- 2-PYRIDONE Antimicrobial Compositionsapplication
- Stable Anthrax Vaccine Formulationsapplication
- Use Of E. Coli Surface Antigen 3 Sequences For The Export Of Heterologous Antigensapplication
- Vaccines Against Clostridium Difficile And Methods Of Useapplication
- Stable Anthrax Vaccine Formulationsapplication
- Novel 2-HETEROARYLOXY-PHENOL Derivatives As Antibacterial Agentsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.